Total Payments
$7,457
2024 Payments
$594.14
Companies
32
Transactions
281
Medicare Patients
6,206
Medicare Billing
$733,720
Payment Breakdown by Category
Food & Beverage$7,101 (95.2%)
Education$356.52 (4.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,101 | 273 | 95.2% |
| Education | $356.52 | 8 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $1,072 | 49 | $0 (2024) |
| ViiV Healthcare Company | $949.39 | 36 | $0 (2024) |
| Janssen Products, LP | $649.32 | 8 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $579.26 | 17 | $0 (2024) |
| GlaxoSmithKline, LLC. | $486.63 | 11 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $450.37 | 17 | $0 (2019) |
| Novo Nordisk Inc | $435.86 | 13 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $427.17 | 24 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $240.89 | 10 | $0 (2022) |
| Lilly USA, LLC | $236.91 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $594.14 | 34 | Gilead Sciences, Inc. ($171.38) |
| 2023 | $368.03 | 25 | ViiV Healthcare Company ($155.50) |
| 2022 | $364.38 | 10 | Paratek Pharmaceuticals, Inc. ($142.21) |
| 2021 | $131.74 | 7 | Janssen Products, LP ($85.00) |
| 2020 | $377.46 | 16 | GlaxoSmithKline, LLC. ($137.60) |
| 2019 | $2,452 | 88 | ViiV Healthcare Company ($395.22) |
| 2018 | $1,773 | 57 | Boehringer Ingelheim Pharmaceuticals, Inc. ($206.51) |
| 2017 | $1,397 | 44 | Gilead Sciences Inc ($310.99) |
All Payment Transactions
281 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $5.43 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.58 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $4.78 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.51 | General |
| 09/06/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: HIV | ||||||
| 08/28/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.63 | General |
| 08/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.72 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE, AVYCAZ | Food and Beverage | In-kind items and services | $4.52 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.26 | General |
| 06/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.16 | General |
| 06/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.71 | General |
| 05/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.07 | General |
| 05/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 05/08/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE, AVYCAZ | Food and Beverage | In-kind items and services | $4.49 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.93 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.53 | General |
| 04/16/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/09/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HIV | ||||||
| 04/06/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: HIV | ||||||
| 03/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $3.50 | General |
| 03/09/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,428 | 2,772 | $622,524 | $165,119 |
| 2022 | 28 | 1,554 | 3,031 | $680,553 | $177,797 |
| 2021 | 27 | 1,626 | 3,211 | $776,017 | $206,136 |
| 2020 | 23 | 1,598 | 2,880 | $729,100 | $184,668 |
Total Patients
6,206
Total Services
11,894
Medicare Billing
$733,720
Procedure Codes
103
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 215 | 661 | $152,030 | $41,826 | 27.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 124 | 283 | $99,050 | $27,049 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 255 | $94,350 | $24,262 | 25.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 79 | 136 | $63,920 | $18,986 | 29.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 116 | 121 | $77,198 | $16,773 | 21.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 129 | 141 | $60,912 | $14,680 | 24.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $17,056 | $4,632 | 27.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 27 | 27 | $10,800 | $3,560 | 33.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 28 | 28 | $7,560 | $2,207 | 29.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 86 | 215 | $3,655 | $1,806 | 49.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 28 | $7,000 | $1,649 | 23.6% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 78 | 186 | $5,394 | $1,542 | 28.6% |
| 80076 | Liver function blood test panel | Office | 2023 | 76 | 182 | $5,096 | $1,458 | 28.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 73 | 173 | $4,498 | $1,317 | 29.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 34 | 53 | $2,650 | $695.36 | 26.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 28 | 28 | $1,624 | $533.68 | 32.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 21 | 28 | $1,618 | $460.88 | 28.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 15 | 15 | $1,485 | $435.15 | 29.3% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 42 | 83 | $913.00 | $258.13 | 28.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 21 | 21 | $2,940 | $224.58 | 7.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 14 | 23 | $920.00 | $218.96 | 23.8% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 11 | 11 | $682.00 | $208.12 | 30.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 12 | 14 | $714.00 | $206.92 | 29.0% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 13 | 17 | $306.00 | $86.36 | 28.2% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2023 | 13 | 17 | $153.00 | $45.05 | 29.4% |
About Dr. Aju Daniel, MD
Dr. Aju Daniel, MD is a Internal Medicine healthcare provider based in Shrewsbury, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2008. The National Provider Identifier (NPI) number assigned to this provider is 1962652560.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aju Daniel, MD has received a total of $7,457 in payments from pharmaceutical and medical device companies, with $594.14 received in 2024. These payments were reported across 281 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($7,101).
As a Medicare-enrolled provider, Daniel has provided services to 6,206 Medicare beneficiaries, totaling 11,894 services with total Medicare billing of $733,720. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Infectious Disease
- Location Shrewsbury, MA
- Active Since 09/19/2008
- Last Updated 05/05/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1962652560
Products in Payments
- DOVATO (Drug) $594.98
- JARDIANCE (Drug) $470.95
- PREZCOBIX (Drug) $416.96
- TRELEGY ELLIPTA (Drug) $415.38
- Biktarvy (Drug) $331.25
- SYMTUZA (Drug) $252.43
- XARELTO (Drug) $212.41
- Symtuza (Drug) $192.93
- Tresiba (Drug) $190.13
- TRIUMEQ (Drug) $186.84
- Ozempic (Drug) $180.73
- Mitra Clip system (Device) $169.44
- BEVESPI AEROSPHERE (Drug) $165.58
- NUZYRA (Drug) $154.21
- AVYCAZ (Drug) $149.43
- Vascepa (Drug) $144.63
- FARXIGA (Drug) $142.87
- DIFICID (Drug) $142.13
- JANUVIA (Drug) $127.38
- TRULICITY (Drug) $126.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Shrewsbury
Jean Casello, Md, MD
Internal Medicine — Payments: $27,754
Internal Medicine $27,754
Mrs. Lisa Golding-Granado, Md, MD
Internal Medicine — Payments: $7,816
Internal Medicine $7,816
Dr. Raymond Zhou, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $6,205
Internal Medicine $6,205
Ms. Sharon Angelo, D.o, D.O
Internal Medicine — Payments: $4,466
Internal Medicine $4,466
Dr. Mai Kaga, M.d, M.D
Internal Medicine — Payments: $1,502
Internal Medicine $1,502
Lizett Marza, Md, MD
Internal Medicine — Payments: $1,202
Internal Medicine $1,202